1,897 reports of this reaction
17.5% of all CALCIUM CARBONATE, MAGNESIUM HYDROXIDE reports
#1 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #1 most commonly reported adverse reaction for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, manufactured by THE PROCTER & GAMBLE MANUFACTURING COMPANY. There are 1,897 FDA adverse event reports linking CALCIUM CARBONATE, MAGNESIUM HYDROXIDE to CHRONIC KIDNEY DISEASE. This represents approximately 17.5% of all 10,871 adverse event reports for this drug.
Patients taking CALCIUM CARBONATE, MAGNESIUM HYDROXIDE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a frequently reported adverse event for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, accounting for a significant proportion of all reports.
In addition to chronic kidney disease, the following adverse reactions have been reported for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 1,897 FDA reports for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 17.5% of all adverse event reports for CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, making it one of the most commonly reported side effect.
If you experience chronic kidney disease while taking CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.